KalVista Pharmaceuticals, Inc. - Company Profile & Contacts
FridayLead tracks 3 contacts at KalVista Pharmaceuticals, Inc.. Below is the company profile and the roles on file. Verified emails and direct phone numbers are unlocked after a free signup.
3
3 contacts in the FridayLead database
Names, emails and phone numbers are hidden until you sign up.
KalVista Pharmaceuticals, Inc. at a glance
- Website kalvista.com
- Industry Biotechnology
- Company size 11-50 employees
- Location Bristol, England, United Kingdom
People at KalVista Pharmaceuticals, Inc.
- Michael Smith - Vice President Clinical Development Salt Lake City, Utah
- Andreas Maetzel - Senior Vice President Medical Cambridge, Massachusetts
- Helen Hernandez - Director Program Management New York, New York
- John Gilday - API Director Bristol, England
- Richard Todd - Drug Substance Manager Slough, England
- Ashley Toomey - Associate, Clinical Trial Salt Lake City, Utah
- Anne Martel - Regional Medical Advisor, KalVista Pharmaceuticals Ocean View, Delaware
- Ed Duckworth - Research Biochemist Bristol, England
Unlock verified emails and phone numbers for KalVista Pharmaceuticals, Inc.
Sign up free to reveal verified business emails and direct phone numbers.
Sign up freeStart free with 500 credits per month. No credit card.
KalVista Pharmaceuticals, Inc. FAQ
How many contacts does KalVista Pharmaceuticals, Inc. have in the FridayLead database?
FridayLead lists 3 contacts at KalVista Pharmaceuticals, Inc.. Sign up free to unlock verified emails and phone numbers.
What industry is KalVista Pharmaceuticals, Inc. in?
KalVista Pharmaceuticals, Inc. is listed under Biotechnology.
What roles work at KalVista Pharmaceuticals, Inc.?
Common roles at KalVista Pharmaceuticals, Inc. include Drug Substance Manager, Regional Medical Advisor, Kalvista Pharmaceuticals, Research Biochemist.
How do I get contact details for KalVista Pharmaceuticals, Inc.?
Create a free FridayLead account to unlock verified business emails and direct phone numbers for KalVista Pharmaceuticals, Inc..